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Nicotinic agonistsThe mechanism of resistance to the anthelmintic levamisole in parasitic nematodes is poorly understood,
although there is some evidence implicating changes in expression of nicotinic acetylcholine receptor
(nAChR) subunit genes. Hence, in order to deﬁne levamisole resistance mechanisms in some Australian
ﬁeld-derived isolates of Haemonchus contortuswe examined gene expression patterns and SNPs in nAChR
subunit genes, as well as expression levels for P-glycoprotein (P-gp) and receptor ancillary protein genes,
in various life stages of one levamisole-sensitive and three levamisole-resistant isolates of this species.
Larvae of two isolates showed high-level resistance to levamisole (resistance ratios at the IC50 > 600)
while the third isolate showed a degree of heterogeneity, with a resistance factor of only 1.1-fold at
the IC50 alongside the presence of a resistant subpopulation. Transcription patterns for nAChR subunit
genes showed a great degree of variability across the different life stages and isolates. The most consis-
tent observation was the down-regulation of Hco-unc-63a in adults of all resistant isolates. Transcription
of this gene was also reduced in the L3 stage of the two most resistant isolates, highlighting its potential
as a resistance marker in the readily accessible free-living stages. There was down regulation of all four
Hco-unc-29 paralogs in adults of one resistant isolate. There were no consistent changes in expression of
P-gps or ancillary protein genes across the resistant isolates. The present study has demonstrated a com-
plex pattern of nAChR subunit gene expression in H. contortus, and has highlighted several instances
where reduced expression of subunit genes (Hco-unc-63a, Hco-unc-29) may be associated with the
observed levamisole resistance. The data also suggests that it will be difﬁcult to detect resistance using
gene transcription-based methods on pooled larval samples from isolates containing only a resistant sub-
population due to the averaging of gene expression data across the whole population.
 2013 Australian Society for Parasitology. Published by Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Intestinal nematode parasites represent a signiﬁcant threat to
veterinary and human health. Control of these nematodes has re-
lied largely on the use of chemicals over the last 50 years, however,
nematodes have shown an ability to develop resistance (Kaplan,
2004; Sutherland and Leathwick, 2011). In Australia, Haemonchus
contortus, Trichostrongylus colubriformis and Teladorsagia circum-
cincta show signiﬁcant levels of resistance to macrocyclic lactone
(ML) and benzimidazole drugs, however, resistance to levamisole
has been slow to develop in H. contortus compared to the two other
species. Hence, this drug has been of particular interest for the con-
trol of benzimidazole- and ML-resistant H. contortus. This situation
is however changing, with resistance to levamisole in H. contortus
increasing over recent years to currently be present on about 20%
of farms in H. contortus-endemic areas of eastern Australia (Love,2011). These levels are still signiﬁcantly lower than the prevalence
of resistances to benzimidazoles or MLs in these areas, and hence
levamisole retains a signiﬁcant place in worm control programmes.
An important component of responsible anthelmintic usage in
the future will be the adoption of surveillance systems for detect-
ing resistance. This will facilitate more informed drug-use deci-
sions based on knowledge of what drug groups will be effective
against particular nematode populations. While a number of
in vitro phenotypic assays for detection of drug resistance are avail-
able (Coles et al., 2006; Kotze et al., 2006; von Samson-Himmelstj-
erna et al., 2009) a simple, cheap and effective molecular test
would be ideal because resistance alleles manifest in a population
well before resistance can be measured as a phenotypic trait
(Martin et al., 1989). However, an understanding of the mecha-
nisms of levamisole resistance, or identiﬁcation of closely-linked
genetic markers, is required before suitable resistance tests for this
drug can be developed (Prichard et al., 2007).
Levamisole acts as an agonist on nicotinic acetylcholine recep-
tors (nAChRs) at the nematode neuromuscular junction, leading
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(Martin et al., 2005; Martin and Robertson, 2007). nAChRs are
comprised of ﬁve subunits arranged around a central ion channel
(Conti-Tronconi et al., 1994). In nematodes, different combinations
of these subunits in an individual receptor confer one of at least
three distinct pharmacological subtypes, of which one (L-type) is
activated preferentially by levamisole (Martin et al., 2005; Martin
and Robertson, 2007). Boulin et al. (2008) reported that ﬁve nAChR
subunits (UNC-63, UNC-38, LEV-8, UNC-29 and LEV-1) were re-
quired to reconstruct a functioning L-type receptor from Caeno-
rhabditis elegans in Xenopus laevis oocytes. However, Williamson
et al. (2009) demonstrated that a functioning receptor can be
formed using just the Ascaris suum UNC-29 and UNC-38 subunits
in a Xenopus expression system. They observed that the stoichiom-
etry of the receptor with respect to UNC-29 and UNC-38 content
profoundly inﬂuenced the sensitivity of the receptor to levamisole
and nicotine. In recent years a number of different forms of L-type
receptor subunits have been reported from H. contortus. Neveu
et al. (2010) identiﬁed two splice variants of the unc-63 gene
(Hco-unc-63a, Hco-unc-63b) while Fauvin et al. (2010) reported
on the existence of two splice variants of the Hco-acr-8 gene
(closely related to Ce-acr-8), Hco-acr-8a and Hco-acr8b. In addition,
Neveu et al. (2010) identiﬁed four paralogs of the Ce-unc-29 gene in
H. contortus: Hco-unc-29.1, .2, .3 and .4.
A number of recent studies have reported on changes in expres-
sion levels of L-type receptor subunit genes that may be associated
with levamisole and pyrantel resistance in parasitic nematodes.
These involve reduced expression of some subunit genes in
pyrantel resistant Ancylostoma caninum (Kopp et al., 2009) and
levamisole resistant H. contortus (Williamson et al., 2011), as well
as the expression of the truncated forms of the unc-63 and acr-8
genes (Hco-unc-63b and Hco-acr-8b) only in levamisole resistant
H. contortus isolates (Neveu et al., 2010; Fauvin et al., 2010;
Williamson et al., 2011). This work has been complimented by
the functional reconstitution of H. contortus nAChRs in Xenopus oo-
cytes which has shown that Hco-UNC-63b has a strong dominant
negative effect on the functioning of a H. contortus nAChR, and have
also demonstrated a critical role for Hco-ACR-8 in levamisole sen-
sitivity (Boulin et al., 2011).
Resistance to nicotinic agonist drugs such as levamisole may
also be due to mutations in genes that do not encode structural
components of the nAChR itself. The proteins RIC-3, UNC-74 and
UNC-50 are known to be essential for the proper formation of
the levamisole receptor, and mutations in each of these genes
can confer levamisole resistance in C. elegans (Martin and
Robertson, 2007). Furthermore, studies have shown that drug
efﬂux mechanisms, particularly P-glycoproteins (P-gps), have po-
tential to play a signiﬁcant role in resistance across different
anthelmintic classes (von Samson-Himmelstjerna and Blackhall,
2005). Finally, an examination of microRNAs (miRNA), especially
the role of mir-1 in C. elegans, suggested that they may be involved
in the negative regulation of expression of key nAChR genes (Simon
et al., 2008). Given the complexity of nAChR pharmacology, and the
potential existence of non-speciﬁc resistance mechanisms (e.g.
P-gps), it is possible that resistance to nicotinic agonist drugs is
polygenic and potentially variable across different helminth
species, or even different isolates within a species.
The present study aimed to investigate levamisole resistance in
H. contortus by examining gene expression patterns in larval and
adult life stages, and in vitro larval nAChR agonist sensitivities, in
one levamisole-susceptible and three levamisole-resistant isolates
of H. contortus. Our aim was two-fold: ﬁrstly to gain insights into
the resistance mechanism(s) used by the various life stages and
isolates, and secondly, to determine whether gene expression pat-
terns in the readily-accessible free-living larval life stages were
indicative of gene expression and resistance status of the adultstages. This latter aim is important if the free-living life stages
are to be a useful source of material for molecular-based tests for
diagnosis of adult worm resistance status. We examined relative
gene expression levels for putative subunit constituents of the
levamisole sensitive receptor (unc-38, unc-29.1–29.4, unc-63a,
unc-63b, lev-1, acr-8a and acr-8b) as well as acr-16 (Martin et al.,
2005), genes coding for receptor ancillary proteins (unc-50,
unc-74, ric-3.1 and ric-3.2), and 10 P-gp genes. We also examined
several of the levamisole sensitive receptor subunit genes listed
above for the presence of SNPs that may be associated with the
observed resistance.
2. Materials and methods
2.1. Collection of worms and eggs
Four isolates of H. contortus were maintained in sheep at the
McMaster Laboratory, CSIRO Livestock Industries, Armidale, New
South Wales (NSW), Australia. Isolates were deﬁned as the follow-
ing, based upon previous in vivo and in vitro data:
(i) Kirby 1986 (K) – isolated from the ﬁeld at the University of
New England Kirby Research Farm in 1986; susceptible to
all commercial anthelmintics (Albers and Burgess, 1988).
(ii) Lawes (LW) – isolated from the ﬁeld near Gatton in south-
eastern Queensland in 1979; resistant to benzimidazoles,
morantel tartrate and levamisole (efﬁcacy 21%) (Green
et al., 1981). Sheep were infected with a defrosted aliquot
of this isolate and were subsequently treated with a full dose
of Nilverm (active ingredient levamisole) 21 days after
infection.
(iii) LevR (LV) – isolated from the Armidale region in New South
Wales in 1980; resistant to levamisole and benzimidazoles
(Le Jambre, unpublished); levamisole efﬁcacy approximately
30% (Kotze, unpublished). Sheep were infected with a
defrosted aliquot of this isolate and were subsequently trea-
ted with a full dose of Nilverm (active ingredient levamisole)
21 days after infection.
(iv) Wallangra 2003 (WAL) – isolated from the New England
region of Northern NSW in 2003; resistant to levamisole
(efﬁcacy 79%), benzimidazoles, closantel and short acting
macrocyclic lactones, such as ivermectin (Love et al.,
2003). This isolate has been selected further using a full dose
of Cydectin (active ingredient moxidectin) over at least ﬁve
generations since it was originally isolated from the ﬁeld.
For the present study, sheep were infected with this isolate
and were subsequently treated with a full dose of Cydectin
21 days after infection.
Eggs were extracted from faeces by passage through two sieves
(250 lm and 75 lm), followed by centrifugation on a sugar gradi-
ent (10% and 25%). Eggs were recovered from the interface be-
tween the sucrose layers and washed over a 25 lm sieve with
water to remove the sucrose, before being treated with bleach as
described by Kotze et al. (2009). The eggs were then washed thor-
oughly to remove the bleach before dilution to a concentration of
approximately 50–60 eggs per 30 ll for use in larval assays. For
recovery of L1 stage larvae, eggs were incubated in a large petri
dish on a layer of 2% agar (Davis Gelatine Co., powdered agar Grade
J) for 24 h at 27 C and then harvested. Third-stage (L3) stage larvae
of each isolate were cultured using a standard coproculture tech-
nique. L1 & L3 stage larvae were divided into 30,000 worm aliquots
and snap frozen in liquid nitrogen prior to storage at 80 C. Adult
worms of the K, LW and LV isolates were collected at necropsy and
microscopically identiﬁed as male or female. Only female WAL
adult worms were available from frozen stocks.
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An in vitro larval development assay (LDA), as described by Gill
et al. (1995), was used to characterize the four isolates with respect
to levamisole, acetylcholine, bephenium and nicotine sensitivities.
Stock drug solutions were prepared at 10 mg/ml in DMSO, and
then serially diluted two-fold in DMSO, and 2 ll aliquots were
added to a 96-well plate. Two hundred microliter of 2% agar (Davis
Gelatine Co., powdered agar Grade J) was dispensed into each well.
Final drug concentration ranges in the assay wells were: levam-
isole 10 – 0.0049 lg/ml, bephenium 10 – 0.078 lg/ml, nicotine
10 – 0.0049 lg/ml, and acetylcholine 10 – 0.078 lg/ml. Plates were
stored at 4 C for up to a fortnight and brought to room tempera-
ture before use. Thirty microliter of egg suspension containing
approximately 50–60 eggs as well as amphotericin B (ﬁnal concen-
tration 25 ll/ml) and tylosin tartare (ﬁnal concentration 800 ll/
ml) was dispensed into each well (Kotze et al., 2009). Plates were
enclosed within a zip lock bag and incubated at 26 C overnight.
An aliquot of a live culture of Escherichia coli was then added to
each well (as described by Kotze et al. (2009)), and the plates were
returned to the incubator for a further 5 days. The larvae were then
killed using Lugol’s iodine solution (10 ll per well). Numbers of L3
and total larvae were counted for each well and the percentage of
L3 larvae calculated for each well. These values were then ex-
pressed as a percentage of the mean of multiple control (no drug)
wells on each assay plate. Three replicate assays (each with tripli-
cate wells at each concentration) were performed for each drug
with each of the H. contortus isolates. Data from the assay was ana-
lyzed using non-linear regression in GraphPad Prism 4™ (Graph-
Pad Software).2.3. Isolation of RNA and cDNA synthesis
Approximately 30,000 L1 or L3 stage larvae, or 15 adult worms
were used for each RNA extraction. RNA was extracted using Trizol
LS™ (Invitrogen) as per manufacturer’s instructions, followed by
treatment with TurboDNase™ (Ambion). cDNA synthesis was per-
formed on extracted RNA with Superscript III™ reverse transcrip-
tase (Invitrogen) according to the manufacturer’s instructions.
cDNA was diluted to a concentration of 2.5 ng/ll for downstream
applications. For each of the isolates and their life stages, cDNA
was generated in three distinct replicates using separate worm
samples for subsequent gene expression and sequencing analysis.2.4. PCR & gene sequence analysis
Primers were designed from published sources and Genbank to
obtain full-length cDNA of genes of interest (Supplementary
Table 1) and PCRs were performed in triplicate using the DNA poly-
merase AmpliTaq Gold (Applied Biosystems). The following cycling
conditions were used with these primer sets with the individual
annealing temperatures (denoted as x below) listed in Supplemen-
tary Table 1: 10 min at 94 C, followed by 40 cycles of 94 C for
30 s, (x) C for 30 s, 72 C for 2 min and a ﬁnal extension period
of 72 C for 8 min. Products were gel-excised and puriﬁed using
Purelink™ (Invitrogen). Puriﬁed gene fragments were stored at
20 C for sequence analysis. The replicates of puriﬁed products
were direct sequenced using the gene-speciﬁc primers and sets
of internal primers, from both 50 and 30 ends to provide approxi-
mately 800 bp reads with an 150 bp overlap. Sequencing results
were analysed using the BLAST algorithm (http://blast.ncbi.nlm.
nih.gov/Blast.cgi) for homology and sequence chromatograms
were analyzed with Chromas™ (Technelysium) and DSGene™
(Accelrys) for the presence of polymorphisms. Quantiﬁcation of
relative frequency of polymorphisms was calculated by measuringpeak heights in Chromas, with each peak value listed as a percent-
age of the total heights at the particular SNP site.
2.5. Quantitative PCR
Primers were designed using DSGene from sequence informa-
tion available on Genbank (Supplementary Tables 2 and 3). Three
housekeeper genes (GAPDH, Actin & 18S) were employed as refer-
ences for the determination of relative expression levels between
the susceptible Kirby isolate and the three resistant isolates. A
7900HT thermocycler (Applied Biosystems) was employed with
the SYBR Green dye system (Applied Biosystems) using the follow-
ing PCR cycling conditions: 50 C for 2 min, 95 C for 10 min, fol-
lowed by 40 cycles 95 C for 15 s, 60 C for 1 min, 95 C for 2 min,
60 C for 15 s. Three separate extractions of each worm isolate
and life-stage, as described earlier, were examined, with each
PCR reaction run in quadruplicate. Reaction efﬁciencies were
determined by performing PCRs using a series of four, ﬁve-fold
cDNA dilutions. Standard curves for all primer pairs indicated an
efﬁciency range between 76% and 99%. Melting curve analysis of
each primer pair identiﬁed the qPCR products to be homogenous
and direct sequencing of these products conﬁrmed the target gene.
Expression values for each gene, in each life-stage of each isolate
were referenced to the three housekeeper genes using REST 2008
software in order to derive a value for the expression of each gene
in a resistant isolate compared to the susceptible isolate. Differ-
ences between resistant and the susceptible isolates were then
examined using a ‘ratio t-test’ on the log of the ratio as described
in the GraphPad Prism handbook. Expression of some genes within
some isolates was too low to generate reproducible Ct values (Ct
values > 35) or visible peaks on dissociation plots. In order to
estimate the degree to which expression of these genes differed
from the isolates where they could be readily detected, standard
curves were used to estimate the maximum Ct value that could
be measured for each gene. These maximum values were used as
estimates for those cases where no product could be detected. In
this way, such approximations represented the minimum degree
of difference between the two isolates being compared. The differ-
ences in gene transcription levels between isolates in these cases
were described as being greater than this minimal value.3. Results
3.1. Larval development assays
Fig. 1 shows the dose response curves describing the effects of
levamisole, bephenium, nicotine and acetylcholine on the develop-
ment of H. contortus larvae. The IC50 and resistance ratio data are
shown in Table 1. Both LV and LW were highly resistant to levam-
isole (resistant ratios at the IC50 > 600). Both isolates also showed a
reduced sensitivity to bephenium and nicotine compared to the K
isolate. The responses of these three isolates to acetylcholine were
similar. The WAL isolate showed no resistance to levamisole at the
EC50 (resistance ratio 1.1). However, this isolate showed the pres-
ence of a resistant fraction of approximately 15% as indicated by
the plateau in the dose response at higher drug concentrations
(Fig. 1). This was reﬂected in a higher resistance ratio at the IC95
of 13-fold (data not shown). WAL larvae also showed low-level
resistance to bephenium, however, they were more sensitive to
both nicotine and acetylcholine than K.
3.2. Sequence analysis
A large number of SNPs were observed amongst the nAChR
genes within the four isolates, however most were silent third
Fig. 1. Effects of nAChR agonists (levamisole, bephenium, nicotine and acetylcholine) on development of H. contortus larvae. Each data point represents mean ± SD, n = 9
assays for levamisole; n = 6 for the other compounds (pooled data from two to three separate experiments, each with assays in triplicate).
Table 1
Effects of nAChR agonists on development of H. contortus larvae (K, drug susceptible
isolate; LW, LV and WAL, drug resistant isolates).
Drug Worm isolate IC50a 95% CI Resistance ratiob
Levamisole K 0.030 0.028–0.032 –
LW 27.1 16.5–44.5 903
LV 20.0 13.1–64.4 668
WAL 0.034 0.029–0.039 1.1
Bephenium K 0.91 0.84–0.98 –
LW 4.69 4.34–5.07 5.2
LV 3.69 3.45–3.94 4.1
WAL 1.58 1.39–1.80 1.7
Nicotine K 0.29 0.25–0.33 –
LW 1.38 1.22–1.56 4.8
LV 0.79 0.61–1.02 2.8
WAL 0.05 0.04–0.06 0.18
Acetylcholine K 2.67 2.51–2.83 –
LW 3.52 3.22–3.85 1.3
LV 3.12 2.97–3.27 1.2
WAL 1.63 1.42–1.87 0.61
a IC50, drug concentration (in lg/ml) required to reduce larval development to
50% of that in control (no drug) assays.
b Resistance ratio, IC50 of resistant strain/IC50 of susceptible strain (K).
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and -.4 gave poor direct sequence results for most isolates and
were therefore omitted from this analysis. Table 2 summarizes
the results for the genes that were sequenced. Two genes,
Hco-unc-63a and Hco-acr-8a, showed amino acid differences be-
tween the isolates. Within the Hco-unc-63a gene of the LW isolate
we observed two distinct changes, R255K and A439S. The ﬁrst
was a complete shift at residue 255 to lysine as compared to
the other isolates that showed arginine only at this position. Res-
idue 439 showed a 70% A:30% S (or 71% A:29% S) ratio across theK, LV and WAL isolates, compared with the LW isolate which was
100% alanine. Other differences observed in Hco-unc-63a between
the various isolates were 33% A423S within LV compared to ala-
nine only in the other isolates, and 27% L488M within K compared
to 100% leucine for the other three isolates. Two changes within
the gene Hco-acr-8a were observed between isolates; a complete
change from lysine to threonine at position 457 in LW only and
5% level of P200L within K compared to lysine only in the other
isolates.3.3. Gene expression
Relative levels of transcription of nAChR subunit and ancillary
protein genes in the resistant isolates (LW, LV and WAL) compared
to the K isolate are shown in Table 3. Highlighted in colour within
the Table are those genes that showed signiﬁcant change (P < 0.05)
in expression. In addition, cases where no product was detected for
a particular gene are highlighted in colour if the estimated expres-
sion difference was >40-fold.
A number of features of this data set are noteworthy. Firstly,
expression changes occurring in the LW and LV isolates were gen-
erally downward in direction while the WAL isolate showed both
increases and decreases in the expression of several genes, relative
to the susceptible K isolate. Secondly, the patterns were often quite
different between the life stages (L1, L3 and adults), as well as be-
tween the sexes for adult worms within each isolate. This was the
case for both the receptor subunit genes and the ancillary protein
genes.
Thirdly, the most consistent change in the resistant isolates was
a reduced expression of Hco-unc-63a. These decreases were up to
5.2-fold for LW and up to 5-fold for LV. Hco-unc-63a was not
detectable in WAL adult females. The decreases in Hco-unc-63a in
LW and LV were not accompanied by changes in Hco-unc-63b,
Table 2
Sequence analysis of nAChR genes from H. contortus isolates (K, drug susceptible isolate; LW, LV and WAL, drug resistant isolates).
Gene Amino acid changes
Position Residues % K % LW % LV % WAL
Hco-unc-38 No changes
Hco-unc-63a 255 Arginine 100 0 100 100
Lysine 0 100 0 0
423 Alanine 100 100 67 100
Serine 0 0 33 0
439 Alanine 71 100 70 70
Serine 29 0 30 30
488 Leucine 73 100 100 100




Hco-acr-8a 200 Leucine 5 100 100 100
Proline 95 0 0 0
457 Lysine 100 0 100 100
Threonine 0 100 0 0
Hco-acr-8b No changes
Table 3
Relative transcription of nAChR subunit and channel ancillary protein genes in various life stages of H. contortus in resistant isolates (LW, LV and WAL) compared to the
susceptible (K) isolate. Signiﬁcant (P<0.05) increases or decreases in transcription in the resistant isolates compared to the susceptible isolate are indicated with color shading.
aNo qPCR result detected in susceptible samples; fold higher expression in resistant isolateP90 (as determined using maximum standard curve Ct values, see text for details).
bNo qPCR result detected in resistant samples; fold lower expression in resistant isolates 60.001.
cNo qPCR result detected in susceptible and resistant samples.
dNo qPCR result detected in resistant samples; fold lower expression in resistant isolate 60.024.
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other hand, signiﬁcant increases in Hco-unc-63b were observed in
WAL L1 and adult females.
A fourth point of note was the absence of Hco-acr-8b from K and
LV adults (both male and female) compared to its presence in LW
and WAL adults. A comparison of Ct values for Hco-acr-8b in these
two isolates with the limits of detection derived from standard
curves showed that the transcription of the gene in LW and WAL
adults was at least 90-fold higher than in K and LV. The increase
in Hco-acr-8b in WAL adult females was accompanied by a
signiﬁcant decrease in the non-truncated version of the gene,
Hco-acr-8a, however there was no change in Hco-acr-8a in LW
adults compared to the susceptible Kirby isolate. In contrast to
adults, the expression of Hco-acr-8b was consistently decreased(P15-fold) in L3 stages of each resistant isolate. A ﬁfth observation
was the down regulation of all Hco-unc-29 paralogs in adults of the
WAL isolate only. Finally, a number of ancillary protein genes
showed reduced expression in the resistant isolates, particularly
Hco-unc-74, however the expression patterns were generally not
consistent across the life stages or isolates.
Levels of transcription of P-gp genes in the three resistant iso-
lates were also compared to the K isolate (Table 4). As with nAChR
genes, there was a great deal of variation in P-gp expression levels
between the different life stages within each isolate. LW and LV
showed both increases and decreases across the various genes,
while WAL showed only increased transcription of several P-gps.
No P-gp gene showed consistent increases in expression across
all life stages in the resistant isolates.
Table 4
Relative transcription of P-gp genes in various life stages of H. contortus in resistant isolates (LW, LV and WAL) compared to the susceptible (K) isolate. Signiﬁcant (P<0.05)
increases or decreases in transcription in the resistant isolates compared to the susceptible isolate are indicated with color shading.
aNo qPCR result detected in resistant samples; fold lower expression in resistant isolates60.001 (as determined using maximum standard curve Ct values, see text for details).
bNo qPCR result detected in susceptible and resistant samples.
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This study represents a comprehensive survey of nAChR sub-
unit, ancillary protein, and P-gp transcription levels in four isolates
of H. contortus of varying sensitivity to levamisole. We have also
examined SNPs in several nAChR subunit genes, and deﬁned
cross-resistance patterns to various nAChR agonists in the free-liv-
ing life stages. A feature of our data was the variability seen in
expression patterns of the various nAChR and ancillary protein
genes across the different isolates and life stages. Despite this,
some gene transcription patterns that may be associated with
the observed resistances in the three levamisole-resistant isolates
emerged from the data.
The most consistent observation was the decrease in expression
of Hco-unc-63a in most life stages/sexes for the resistant isolates.
Kopp et al. (2009) found that transcription of Acn-unc-63 was re-
duced in both adult and L3 life stages of an isolate of A. caninum
showing reduced sensitivity to pyrantel. However, the decreases
observed in Hco-unc-63a in the present study were on their own
not sufﬁcient to explain the observed levels of levamisole resis-
tance in adult worms: while the expression of this gene could still
be detected in the highly resistant LW and LV isolates (at much
lower levels than the susceptible K isolate), it was undetectable
in the WAL isolate which showed a much lower level of resistance
to the drug compared to LW and LV. Hence, the degree of
resistance shown by the three isolates is clearly not directly pro-
portional to expression of Hco-unc-63a in adult worms. The main-
tenance of a degree of sensitivity to levamisole in WAL adults
(drench efﬁcacy approximately 79%, Love et al., 2003) suggests that
levamisole-sensitive nAChRs in WAL must form in the absence of
UNC-63. The lack of a direct relationship between levamisole
sensitivity and unc-63a expression suggests that the high levels
of resistance observed in LW and LV adults involves additional
mechanisms to the suggested role of reduced unc-63a expression.
Alternatively, it may be possible that the composition of levam-
isole-sensitive receptors varies between the different isolates such
that the consequences of reduced expression of unc-63a are more
signiﬁcant in terms of sensitivity to the drug for LW and LV than
for WAL due to the presence of alternative levamisole-sensitive
receptors in the latter. This is, however, speculative, and requires
further study.
The apparent absence of unc-63a from WAL adult females is
surprising. While impaired expression of unc-63 in C. elegans re-
sults in a strong resistance to levamisole, this is accompanied by
a degree of locomotor dysfunction (Culetto et al., 2004; Sleigh,
2010). On the other hand, the present study suggests thatH. contortus worms are quite viable when unc-63a expression is
greatly reduced or undetectable.
Signiﬁcantly, while unc-63a transcription was reduced in adults
of all three resistant isolates, this reduction was not consistent
across L3 life stages of the resistant isolates, as it did not occur with
WAL larvae, indicating that it would not be a universal free-living
life stage marker for resistance. However, the response of WAL lar-
vae to levamisole in the LDA in the present study may be of signif-
icance in interpreting these gene expression data. WAL larvae did
not show any resistance to the drug at the IC50 in the LDA com-
pared to the Kirby isolate (from Fig. 1 and Table 1), however, a sub-
population of WAL larvae showed a signiﬁcant level of resistance
(plateau at approximately 15% larval development at higher drug
concentrations from Fig. 1, resistance factor at the IC95 of 13-fold).
Measurement of gene expression levels in a sample derived from
the entire WAL larval population would represent an average
across all the larvae present in that population, and hence may
not be indicative of the transcription patterns in the more resistant
fraction of the population. Any anthelmintic resistance diagnostic
based on measurement of gene transcription in whole larval pop-
ulations showing the type of heterogeneity in dose response as
for WAL in Fig. 1 would potentially be distorted by this same aver-
aging issue. The shape of the larval dose response curve would be
critical as shifts in IC50 would be more likely to be detectable
through measurements of whole population gene transcription
patterns than shifts in IC95 alone.
A striking result with adult stage worms was the decrease in the
transcription levels of all Hco-unc-29 paralogs in females of the
WAL isolate. These decreases ranged from 7-fold for Hco-unc-29.4
up to 250-fold for Hco-unc-29.3. Williamson et al. (2009) showed
that as the level of Asu-unc-29 relative to Asu-unc-38 decreased
in their Xenopus oocyte expression system, there was a decrease
in the sensitivity to levamisole, which changed from being a full
agonist to only a partial agonist. This is consistent with our ﬁnding
of reduced expression of Hco-unc-29 alongside equivalent Hco-unc-
38 levels in adults of the resistant WAL isolate compared to the
susceptible K isolate. Signiﬁcantly, though, these reductions in
Hco-unc-29 transcription levels were not observed in WAL larvae
despite this isolate showing the presence of a resistant subpopula-
tion observable at higher drug concentrations in the LDA (from
Fig. 1). As described above for Hco-unc-63a, this may be at least
partly due to the averaging of transcription data across a pooled
larval sample; that is, Hco-unc-29 expression levels measured in
a sample of the entire population may not be indicative of levels
in the resistant fraction of the population. Hence, as for Hco-
unc-63a, the results for Hco-unc-29 in the free living stages would
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and levamisole resistance status of adults from ﬁeld isolates show-
ing gene expression/resistance patterns similar to WAL.
Previous studies have reported the presence of Hco-acr-8b (the
truncated isoform of Hco-acr-8a) in resistant isolates of H. contortus
(Fauvin et al., 2010; Williamson et al., 2011). Similarly, we found
Hco-acr-8b to be transcribed at readily detectable levels in LW and
WAL adult worms, but absent in levamisole-sensitive K worms.
However, it was also undetectable in LV adults. Hence, while it
may be associated with resistance in the two former resistant iso-
lates, our results suggest thatworms can be resistantwithout show-
ing the presence of Hco-acr-8b. L1 and L3 stage larvae of all three
resistant isolates showed equal or lower transcription of this gene
compared to K. Hence, even if the presence of Hco-acr-8bwas asso-
ciated with levamisole resistance in adult LW and WAL worms,
measurement of relative transcription in free-living life stages of
susceptible and resistant isolates would not be a useful indicator
of adult worm resistance status in these isolates.
We found that Hco-unc-63b was present in all life stages and
isolates, both susceptible and resistant, in contrast to its reported
absence in adult males of the susceptible isolates of H. contortus
examined by Neveu et al. (2010). The only signiﬁcant differences
between resistant and susceptible isolates with respect to this gene
in the present study were a reduced level of transcription in LW L3,
and increased transcription in L1 and adult female WAL worms.
The expression levels of this gene were not altered in the highly
resistant LW and LV adult life stages compared to Kirby. Hence,
among our set of isolates, measurement of relative levels of Hco-
unc-63b was not informative with respect to resistance status.
The three levamisole resistant isolates were also resistant to
bephenium in LDAs, with the degree of resistance to the two drugs
being consistent among the three isolates (LW > LV >WAL). This
cross resistance may be due to parallel changes in a subset of
receptors which are sensitive to both drugs. Charvet et al. (2012)
recently showed that bephenium could activate an L-type H.
contortus receptor (Hco-L-AChR1) expressed in Xenopus oocytes.
In contrast, Kopp et al. (2009) found an inverse relationship be-
tween sensitivity to levamisole and bephenium in larvae of two
isolates of A. caninum. These authors suggested that the inverse
relationship may have been due to a compensatory increase in
B-type receptors in the face of a decrease in L-type receptors as a
response to pyrantel selection pressure in order to maintain a
stable net nAChR population. Such compensatory changes were
not apparent in the present study with respect to any of the nAChR
agonists examined with the LW and LV isolates which showed
decreased sensitivity to levamisole, bephenium and nicotine
alongside equivalent sensitivity to acetylcholine as the K isolate.
We did not ﬁnd any clear role for P-gps in the observed levam-
isole resistances. Hco-pgp-3 and -4 were increased in some life
stages of LW and LV, however these increases were not consistent
across all life stages for either gene. WAL showed increased tran-
scription of several P-gp genes compared to K, however these
changes were variable across the different life stages, and they can-
not be linked to levamisole resistance as this isolate is also highly
resistant to macrocylic lactone and benzimidazole anthelmintics
(Love et al., 2003). P-gps have been implicated in resistance to both
these chemical groups (Blackhall et al., 1998, 2008). In contrast to
Williamson et al. (2011) we did not ﬁnd any increase in Hco-pgp-2
in the multidrug resistant WAL isolate.
We also found no evidence that SNPs in nAChR genes were
responsible for the observed levamisole resistances. Most of the
SNPs we detected were silent third base mutations, while the small
number that resulted inaminoacid changeswereunlikely tohavean
impact on levamisole sensitivity due to similarities between the two
amino acids or the relatively small change in the percentage occur-
rence of the SNP. It is notable that a glutamic acid residue in theligand binding domain of Hco-unc-38, reported to be essential for
sensitivity to levamisole and pyrantel, and a glutamate residue in
the ligand binding domain of unc-63 essential for pyrantel sensitiv-
ity (MartinandRobertson, 2007)were100%present in all isolateswe
examined. Koppet al. (2009) also foundnoevidence for a roleof SNPs
in unc-29, -38 and -63 genes in sensitivity of A. caninum to pyrantel.
An interesting feature of the gene expression data was the dif-
ference in relative expression of some genes between male and fe-
male worms of the resistant and susceptible isolates. While
expression of nAChR subunit genes may be expected to differ
somewhat between male and female worms, for example, due to
their role in egg laying (Schafer, 2006), it is less clear why levam-
isole resistant/susceptible comparisons would differ in male and
female worms; for instance Hco-ric-3.1 was 2-fold lower in LV fe-
males compared to K females, while being almost 5-fold higher
in LV males compared to K males. Nevertheless, as both male
and female worms of levamisole resistant isolates are able to with-
stand the effects of drench treatments, it is most likely that
changes in nAChRs which confer resistance in a population of
worms will be observed in both sexes.
Taken together, the present study and previous reports on
mechanisms of levamisole and pyrantel resistance in H. contortus,
T. circumcincta, T. colubriformis and A. caninum point to possible
roles for changes in a number of nAChR subunit genes in resistance
to nAChR agonist anthelmintics: presence of Hco-acr-8b (Fauvin
et al., 2010; Williamson et al., 2011), presence of Hco-unc-63b
(Neveu et al., 2010), reduced transcription of unc-63a (the present
study; Kopp et al., (2009); Williamson et al., 2011), reduced tran-
scription of unc-38 (Kopp et al., 2009), and reduced transcription
of unc-29 (the present study; Kopp et al., (2009)). It is possible that
levamisole/pyrantel resistance may arise through different
mechanisms in different worm isolates and species (Martin and
Robertson, 2007). The isolates examined in the present study differ
in their time of isolation from the ﬁeld (LW and LV in the 1980s,
WAL in 2003) and their geographical locations in northern NSW
and southern Queensland. Further, these isolates may be quite dif-
ferent to the African, European and New Zealand isolates of the
three species examined by Fauvin et al. (2010) and Neveu et al.
(2010), and the American isolate of H. contortus examined by Wil-
liamson et al. (2011). In addition, the quite different expression
patterns observed in the present study for some of the genes listed
above in resistant L1 and L3 larvae compared to adult worms pro-
vides a further level of complexity to efforts to elucidate resistance
mechanisms and identify suitable diagnostic markers for levam-
isole resistance. Despite this, transcription patterns for Hco-unc-
63a in LW and LV larvae in the present study were in concordance
with adult gene expression levels and levamisole resistance status,
suggesting that larval unc-63a levels may be a useful resistance
diagnostic for at least a subset of levamisole resistant isolates.
However, our study also suggests that it is may be difﬁcult to asso-
ciate larval gene transcription patterns with resistance in isolates
showing heterogeneity in drug sensitivity in the larval stages such
as WAL. Measurement of the average transcription levels across
the whole larval population in such isolates may not be indicative
of levels in a resistant fraction within the population.Acknowledgements
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